Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, July 4 2009 6:22am ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Delivery News
View: Latest News | Top Stories
Friday, Jul 3, 2009
·Big Win for J&J with Elan Deal
at Seeking Alpha - Fri 5:43 am ET
·J&J comes riding to Elan's rescue
at Seeking Alpha - Fri 5:35 am ET
Thursday, Jul 2, 2009
·Elan, Nobility Homes: Biggest Price Gainers (ELN, NOBH)
at The Wall Street Journal Online - Thu 4:53 pm ET
·Elan Shares Spike on JNJ Investment News
at Seeking Alpha - Thu 3:26 pm ET
·[external] Top Takes From RealMoney
at TheStreet.com - Thu 2:37 pm ET
·[video] Drugs & Deals
at CNBC - Thu 2:26 pm ET
·[external] Biotech Stocks: Drug stocks slide; Elan climbs on J&J deal
at MarketWatch - Thu 1:41 pm ET
·Elan, Evergreen Solar: Biggest Price Gainers (ELN, ESLR)
at The Wall Street Journal Online - Thu 12:45 pm ET
·Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
PR Newswire - Thu 7:57 am ET
·Acura, King get FDA response on Acurox
at MarketWatch - Thu 7:10 am ET
·Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
PR Newswire - Thu 7:00 am ET
Wednesday, Jul 1, 2009
·The Emisphere Story Just Got Bigger
at Seeking Alpha - Wed Jul 1
Tuesday, Jun 30, 2009
·[$$] Biogen Reports a 13th Sick Patient on MS Drug
at The Wall Street Journal Online - Tue Jun 30
·Hospira Injection Gets FDA Clearance
Zacks.com - Tue Jun 30
·Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
PR Newswire - Tue Jun 30
·ULURU Inc. Announces Revised Business Plan
PR Newswire - Tue Jun 30
Monday, Jun 29, 2009
·Hospira Receives FDA Approval for Azithromycin for Injection
PR Newswire - Mon Jun 29
·NovaDel Receives Commitment of Investment Fund to Purchase up to 13.0 Million Shares over the Next 12 Months
Business Wire - Mon Jun 29
·Generex Sees Favorable Results From MetControl(tm) Chewing Gum Bio-equivalency Study Leading to Global Product Submissions
GlobeNewswire - Mon Jun 29
·[external] Biogen Reports 10th PML Case With Tysabri
at TheStreet.com - Mon Jun 29
More Latest News...
Sponsor Results
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial.
www.GFTforex.com
Earn From 2.35% to 2.65%
With GE Capital Corporation. Not An Offer Of Securities For Sale.
www.geinterestplus.com
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today.
www.sharebuilder.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Drug Delivery Headlines
More Finance RSS Feeds


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?